I opened a position in this stock at the end of March 2006.
Their Excimer laser technology delivers relatively cool ultraviolet energy to ablate or remove arterial blockages including plaque, calcium and thrombus. The Company claims its CVX-300(R) excimer laser is the only system approved in the United States, Europe, Japan, and Canada for use in multiple, minimally invasive cardiovascular procedures. These procedures include atherectomy, which is a procedure to remove arterial blockages in the peripheral or coronary vasculature, and the removal of infected, defective or abandoned cardiac lead wires from patients with pacemakers or implantable cardiac defibrillators, or ICDs, which are electronic devices that regulate the heartbeat.
To put it in simple terms, their technology is enabling patients who would otherwise need to have amputations to avoid such surgery. Diabetics are particularly vulnerable to such surgery and 85% of which may have been unnecessary.
In June, SPNC was ranked 56th on Fortune's Small Business 100 List of the fastest growing small companies.
Check out the news releases at…
*ttp://investor.spectranetics.com
